Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka.

IF 2.7 3区医学 Q2 DERMATOLOGY

Dermatology Pub Date : 2025-07-07 DOI:10.1159/000539336

Kanchana Viraj Mallawaarachchi, Chathurika Gangani, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec

{"title":"Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka.","authors":"Kanchana Viraj Mallawaarachchi, Chathurika Gangani, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec","doi":"10.1159/000539336","DOIUrl":null,"url":null,"abstract":"Introduction: Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicles in the apocrine gland-bearing areas of the body. The global HS prevalence has been reported in the range of 0.00033-4.1%. It is reportedly rarer in Asia.Methods: The study aimed to establish the prevalence of hidradenitis suppurativa (HS) in a Sri Lankan hospital setting. An explorative, cross-sectional, descriptive study was done on a sample of accompanying healthy persons to patients at Base Hospital, Balangoda, Sri Lanka. The study was conducted over a 6-month period (November 1st, 2022, to April 30th, 2023) and was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative. The data were collected using validated self-administered questionnaire. When the questionnaire indicated HS (screen-positive), the study participant was referred to the consultant dermatologist, who examined the individual and confirmed the final diagnosis based on three obligatory diagnostic criteria (i.e., typical lesion, typical topography, and the chronicity and recurrence).Results: Of 993 participants, the prevalence of HS was 0.2 (95% confidence interval 0.06%-0.73%). The difference in median age between two groups (i.e., individuals with HS - positive group and the control group) was statistically significant (p = 0.01802). The HS group was relatively younger with a median age of 26.5 (23.8-29.3) years, while that of the control group was 54.0 (48.0-59.0).Conclusion: Hidradenitis suppurativa is rare in Sri Lanka as in other Asia-pacific countries.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233961/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000539336","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicles in the apocrine gland-bearing areas of the body. The global HS prevalence has been reported in the range of 0.00033-4.1%. It is reportedly rarer in Asia.

Methods: The study aimed to establish the prevalence of hidradenitis suppurativa (HS) in a Sri Lankan hospital setting. An explorative, cross-sectional, descriptive study was done on a sample of accompanying healthy persons to patients at Base Hospital, Balangoda, Sri Lanka. The study was conducted over a 6-month period (November 1st, 2022, to April 30th, 2023) and was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative. The data were collected using validated self-administered questionnaire. When the questionnaire indicated HS (screen-positive), the study participant was referred to the consultant dermatologist, who examined the individual and confirmed the final diagnosis based on three obligatory diagnostic criteria (i.e., typical lesion, typical topography, and the chronicity and recurrence).

Results: Of 993 participants, the prevalence of HS was 0.2 (95% confidence interval 0.06%-0.73%). The difference in median age between two groups (i.e., individuals with HS - positive group and the control group) was statistically significant (p = 0.01802). The HS group was relatively younger with a median age of 26.5 (23.8-29.3) years, while that of the control group was 54.0 (48.0-59.0).

Conclusion: Hidradenitis suppurativa is rare in Sri Lanka as in other Asia-pacific countries.

查看原文本刊更多论文

斯里兰卡巴兰哥达地区化脓性汗腺炎的流行情况。

简介：化脓性汗腺炎（HS）是一种慢性、炎症性、复发性、衰弱性的皮肤疾病，发生在人体大汗腺携带区域的毛囊。据报道，全球HS患病率为0.00033-4.1%。据报道，这种病在亚洲比较罕见。方法：本研究旨在确定化脓性汗腺炎（HS）在斯里兰卡医院的流行情况。对斯里兰卡巴兰哥达基地医院的陪同患者的健康人员样本进行了一项探索性、横断面、描述性研究。该研究为期6个月（2022年11月1日至2023年4月30日），是全球化脓性汗腺炎地图集（GHiSA）计划的一部分。数据收集采用有效的自我管理问卷。当问卷显示HS（筛检阳性）时，研究参与者被转介给皮肤科会诊医师，会诊医师对患者进行检查，并根据三个强制性诊断标准（即典型病变、典型地形、慢性和复发）确定最终诊断。结果：993名参与者中，HS患病率为0.2（95%可信区间为0.06% ~ 0.73%）。两组（即HS -阳性组与对照组）的中位年龄差异有统计学意义（p = 0.01802）。HS组相对年轻，中位年龄26.5（23.8 ~ 29.3）岁，对照组为54.0（48.0 ~ 59.0）岁。结论：化脓性汗腺炎在斯里兰卡与其他亚太国家一样罕见。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dermatology 医学-皮肤病学

CiteScore

6.40

自引率

2.90%

发文量

审稿时长

1 months

期刊介绍： Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.